CT评估心肌细胞外容积以MRI为参考:系统综述与荟萃分析
该系统综述与荟萃分析纳入17项研究共459例患者和2231个心肌节段,评估CT测量心肌细胞外容积(CT-ECV)以MRI为参考的可靠性。结果显示CT-ECV与MRI-ECV在患者水平平均差0.07%、相关系数0.89,在节段水平平均差0.44%、相关系数0.84;ECViodine法相关系数高于ECVsub法(0.94 vs 0.84,p=0.03),室间隔节段相关系数高于非室间隔节段(0.88 vs 0.76,p=0.009)。结论认为CT与MRI的ECV定量具有良好一致性和极好相关性,是潜在有吸引力的MRI替代方法。
要点
- CT-ECV与MRI-ECV在患者水平相关系数0.89(95%CI 0.86-0.91),平均差0.07%(95%LOA -0.42至0.55%)。
- 节段水平相关系数0.84(95%CI 0.82-0.85),平均差0.44%(95%LOA 0.16-0.72%)。
- ECViodine法相关系数0.94(95%CI 0.91-0.96)高于ECVsub法0.84(95%CI 0.80-0.88),p=0.03。
核心结论
- CT与MRI在ECV定量方面显示出良好一致性和极好相关性,是潜在有吸引力的MRI替代方法。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、EMBASE和Cochrane Library自建库至2022年7月发表的相关文章,纳入比较CT-ECV与MRI参考的17项研究,共459例患者和2231个心肌节段。
诊断标准与关键数值
- 患者水平:CT-ECV与MRI-ECV的汇总平均差0.07%(95%LOA -0.42至0.55%),相关系数r=0.89(95%CI 0.86-0.91)。
- 节段水平:汇总平均差0.44%(95%LOA 0.16-0.72%),相关系数r=0.84(95%CI 0.82-0.85)。
- ECViodine法汇总r=0.94(95%CI 0.91-0.96) vs ECVsub法r=0.84(95%CI 0.80-0.88),p=0.03。
- 室间隔节段汇总r=0.88(95%CI 0.86-0.90) vs 非室间隔节段r=0.76(95%CI 0.71-0.90),p=0.009。
临床应用与阅片要点
- CT-ECV可作为MRI-ECV的可行替代方法用于ECV定量。
- 采用ECViodine法进行CT-ECV定量较ECVsub法显示出更准确的心肌ECV定量。
- 室间隔心肌节段在ECV定量中显示出较非室间隔节段更低的测量变异性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Myocardial extracellular volume (ECV) fraction is an important imaging biomarker in clinical decision-making. CT-ECV is a potential alternative to MRI for ECV quantification. We conducted a meta-analysis to comprehensively assess the reliability of CT for ECV quantification with MRI as a reference.
METHODS: We systematically searched PubMed, EMBASE, and the Cochrane Library for relevant articles published since the establishment of the database in July 2022. The articles comparing CT-ECV with MRI as a reference were included. Meta-analytic methods were applied to determine the pooled weighted bias, limits of agreement (LOA), and correlation coefficient (r) between CT-ECV and MRI-ECV.
RESULTS: Seventeen studies with a total of 459 patients and 2231 myocardial segments were included. The pooled mean difference (MD), LOA, and r for ECV quantification at the per-patient level was (0.07%; 95% LOA: - 0.42 to 0.55%) and 0.89 (95% CI: 0.86-0.91), respectively, while on the per-segment level was (0.44%; 95% LOA: 0.16-0.72%) and 0.84 (95% CI: 0.82-0.85), respectively. The pooled r from studies with the ECViodine method for ECV quantification was significantly higher compared to those with the ECVsub method (0.94 (95% CI: 0.91-0.96) vs. 0.84 (95% CI: 0.80-0.88), respectively, p = 0.03). The pooled r from septal segments was significantly higher than those from non-septal segments (0.88 (95% CI: 0.86-0.90) vs. 0.76 (95% CI: 0.71-0.90), respectively, p = 0.009).
CONCLUSION: CT showed a good agreement and excellent correlation with MRI for ECV quantification and is a potentially attractive alternative to MRI.
CLINICAL RELEVANCE STATEMENT: The myocardial extracellular volume fraction can be acquired using a CT scan, which is not only a viable alternative to myocardial extracellular volume fraction derived from MRI but is also less time-consuming and costly for patients.
KEY POINTS: • Noninvasive CT-ECV is a viable alternative to MRI-ECV for ECV quantification. • CT-ECV using the ECViodine method showed more accurate myocardial ECV quantification than ECVsub. • Septal myocardial segments showed lower measurement variability than non-septal segments for the ECV quantification.
引用
- Zhang, Guo, Liu, et al. CT for the evaluation of myocardial extracellular volume with MRI as reference: a systematic review and meta-analysis. Eur Radiol. 2023. PMID: 37378712. doi:10.1007/s00330-023-09872-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。